ASHP® Injectable Drug Information™

A Comprehensive Guide to Compatibility and Stability

ASHP (Autor)

Buch | Hardcover

1600 Seiten

2022
American Society of Health-System Pharmacists (Verlag)
978-1-58528-683-6 (ISBN)

Artikel merken

For more than 40 years ASHP has published the most trusted resource for injectable drug information. The ASHP Injectable Drug Information now delivers the same high-quality content that you can expect from ASHP with even more of the information you need to make decisive patient care decisions.

For more than 40 years ASHP has published the most trusted resource for injectable drug information. Our new ASHP® Injectable Drug Information now delivers the same high-quality content that you can expect from ASHP with even more of the information you need to make decisive patient care decisions.

The 2023 edition of the industry's go-to guide is newly updated with the latest information, the full list of the AHFS® Pharmacologic-Therapeutic Classification© system, multiple new monographs, and nearly 200 new references for a total of over 24,000 total compatibility pairs.

ASHP® Injectable Drug Information™ 2023 features more than 400 monographs, including:

Brexanolone
Cefiderocol sulfate tosylate
Oritavancin
Oliceridine fumarate
Remdesivir
Remimazolam besylate
Sildenafil citrate

Erscheinungsdatum	31.10.2022
Verlagsort	Bethesda
Sprache	englisch
Gewicht	3972 g
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
ISBN-10	1-58528-683-4 / 1585286834
ISBN-13	978-1-58528-683-6 / 9781585286836
Zustand	Neuware